...
首页> 外文期刊>BMC Pediatrics >Use of plasma mitochondrial DNA levels for determining disease severity and prognosis in pediatric sepsis: a case control study
【24h】

Use of plasma mitochondrial DNA levels for determining disease severity and prognosis in pediatric sepsis: a case control study

机译:血浆线粒体DNA水平在确定儿童败血症疾病严重程度和预后中的应用:病例对照研究

获取原文
           

摘要

The mortality rate due to severe sepsis is approximately 30–60%. Sepsis readily progresses to septic shock and multiple organ dysfunction, representing a significant problem in the pediatric intensive care unit (PICU). The aim of this study was to explore the value of plasma mitochondrial DNA (mtDNA) for early diagnosis and prognosis in children with sepsis. A total of 123 children with sepsis who were hospitalized in the Hunan Children’s Hospital PICU from July 2013 to December 2014 were divided into the general sepsis group (n?=?70) and severe sepsis group (n?=?53) based on diagnostic standards. An additional 30 children with non-sepsis infection and 30 healthy children were randomly selected as a control group. Patients’ plasma was collected during admission to the PICU. A pediatric critical illness score (PCIS) was also calculated. The plasma mtDNA level was examined using real-time polymerase chain reaction technology, and other parameters including routine laboratory values; blood lactate, procalcitonin (PCT), and C-reactive protein (CRP) levels; and data on survival were collected and compared among the groups. The plasma mtDNA level in the sepsis group than that in the non-sepsis infection and healthy groups. The plasma mtDNA level was significantly higher in the severe sepsis than in the general sepsis group (p?
机译:严重败血症导致的死亡率约为30-60%。败血症容易发展为败血性休克和多器官功能障碍,这在小儿重症监护病房(PICU)中是一个重大问题。这项研究的目的是探讨血浆线粒体DNA(mtDNA)对败血症患儿的早期诊断和预后的价值。根据诊断,2013年7月至2014年12月在湖南省儿童医院PICU住院的123例败血症患儿分为普通败血症组(n?=?70)和重症败血症组(n?=?53)。标准。随机选择另外30名非败血症感染儿童和30名健康儿童作为对照组。患者入院期间收集血浆。还计算了小儿危重疾病评分(PCIS)。使用实时聚合酶链反应技术和其他参数(包括常规实验室值)检查血浆mtDNA水平。血乳酸,降钙素原(PCT)和C反应蛋白(CRP)水平;并收集生存数据并在各组之间进行比较。败血症组的血浆mtDNA水平高于非败血症感染组和健康组。重症脓毒症患者的血浆mtDNA水平显着高于普通败血症组(p <0.001)。较低的PCIS与较高的血浆mtDNA水平相关(p <0.001)。功能障碍的器官数量增多与血浆mtDNA水平升高有关(p <0.001)。丙氨酸转氨酶,天冬氨酸转氨酶,血尿素氮,肌酐,乳酸脱氢酶,肌酸激酶,肌红蛋白,肌酸激酶MB和肌钙蛋白升高的患者血浆mtDNA水平高于正常范围内的患者。非幸存者中的mtDNA水平高于幸存者,并且这一差异是显着的。 mtDNA的预后预测值与乳酸,PCT和CRP相似。血浆mtDNA水平可能是败血症患儿诊断和预后的合适生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号